Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gullestad

Showing results (351-360 of 382) with videos related to

Pageof 39
Sort By:
Plos One|March 20, 2012
The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failureArne Yndestad, Alexandra Vanessa Finsen, Thor Ueland, et al.
European Journal of Heart Failure|March 30, 2013
EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)Aldo P Maggioni, Ulf Dahlström, Gerasimos Filippatos, et al.
Journal of the American College of Cardiology|December 10, 2021
Microcirculatory Resistance Predicts Allograft Rejection and Cardiac Events After Heart TransplantationJung-Min Ahn, Frederik M Zimmermann, Lars Gullestad, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 2006
Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilizationJan K Damås, Camilla Smith, Erik Øie, et al.
Genome Medicine|February 8, 2024
Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severitySajan C Raju, Antonio Molinaro, Ayodeji Awoyemi, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Proteogenomic integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosisSavvina Prapiadou, Luka Živković, Barbara Thorand, et al.
European Journal of Heart Failure|September 30, 2017
Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF studyPaul Welsh, Lei Kou, Changhong Yu, et al.
Open Heart|August 17, 2023
Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumabSindre Woxholt, T Ueland, Pål Aukrust, et al.
Circulation|December 28, 2023
Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on AtherosclerosisSavvina Prapiadou, Luka Živković, Barbara Thorand, et al.
European Heart Journal|October 19, 2021
Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantationJung-Min Ahn, Frederik M Zimmermann, Satish Arora, et al.
Pageof 39

Showing results (351-360 of 382) with videos related to

Sort By:
Pageof 39
Plos One|March 20, 2012
The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failureArne Yndestad, Alexandra Vanessa Finsen, Thor Ueland, et al.
European Journal of Heart Failure|March 30, 2013
EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)Aldo P Maggioni, Ulf Dahlström, Gerasimos Filippatos, et al.
Journal of the American College of Cardiology|December 10, 2021
Microcirculatory Resistance Predicts Allograft Rejection and Cardiac Events After Heart TransplantationJung-Min Ahn, Frederik M Zimmermann, Lars Gullestad, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 2006
Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilizationJan K Damås, Camilla Smith, Erik Øie, et al.
Genome Medicine|February 8, 2024
Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severitySajan C Raju, Antonio Molinaro, Ayodeji Awoyemi, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Proteogenomic integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosisSavvina Prapiadou, Luka Živković, Barbara Thorand, et al.
European Journal of Heart Failure|September 30, 2017
Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF studyPaul Welsh, Lei Kou, Changhong Yu, et al.
Open Heart|August 17, 2023
Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumabSindre Woxholt, T Ueland, Pål Aukrust, et al.
Circulation|December 28, 2023
Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on AtherosclerosisSavvina Prapiadou, Luka Živković, Barbara Thorand, et al.
European Heart Journal|October 19, 2021
Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantationJung-Min Ahn, Frederik M Zimmermann, Satish Arora, et al.
Pageof 39